Annual breast cancer screening that includes magnetic resonance imaging (MRI) reduces the frequency of advanced breast cancers among women with a BRCA1 or BRCA2 mutation. These results were published in the Journal of Clinical Oncology. Inherited mutations in two genes—BRCA1 …
Tag: breast cancer
Diagnosis of Early Breast Cancer Doesn’t Shorten Life Expectancy of Older Women
Among women age 67 or older, a diagnosis of ductal carcinoma in situ (DCIS) or Stage I breast cancer doesn’t appear to worsen survival survival is similar to that of older women without breast cancer. Diagnosis of more advanced breast …
Breast Cancer Rates No Longer Declining
After a sharp decline in breast cancer rates between 2002 and 2003 among non Hispanic white women in the US, overall breast cancer rates did not change significantly between 2003 and 2007. These results were published in Cancer Epidemiology, Biomarkers, …
Halaven Improves Survival with Metastatic Breast Cancer
Among women with previously treated, locally recurrent or metastatic breast cancer, treatment with the chemotherapy drug Halaven™ (eribulin mesylate) improved overall survival by 2.5 months. The results of this Phase III clinical trial were published in The Lancet. Metastatic breast …
Mammography Less Accurate for Detection of Second Cancers
Among women with a personal history of breast cancer, mammography can detect second cancers at an early stage, but may be less accurate than among women who have never had breast cancer. These results were published in the Journal of …
Obesity Linked with Triple-Negative Breast Cancer
Women who are obese and not physically active may be more likely than other women to develop triple negative breast cancer (breast cancer that is estrogen receptor negative, progesterone receptor negative, and HER2 negative). These results were published in Cancer …
Study Evaluates Predictors of DCIS Outcomes
Choice of treatment, choice of surgeon, and surgical margin (a measure of whether the cancer was completely removed) all appear to affect the risk of disease recurrence among women with ductal carcinoma in situ (DCIS) of the breast. These findings …
Lasofoxifene Promising for Breast Cancer Prevention Among Postmenopausal Women with Osteoporosis
Lasofoxifene, a selective estrogen receptor modulator (SERM), appears to reduce the risk of breast cancer among postmenopausal women with osteoporosis. These findings were recently reported in the Journal of the National Cancer Institute. As a SERM, the investigational drug lasofoxifene …
Breast Cancer PSA 2011
Binoculars for a Cause Alpen Pink 393p for Breast Cancer Video!
binocularexpress.com Alpen PINK 393P 10×42 Binoculars Model: 393P Shipping Method: Free Shipping Products Condition: New Manufacturer: Alpen Why PINK? Pink is the color most associated with breast cancer research. With more than 40000 Americans dying each year of breast cancer,…
Source: YouTube